Prime Medicine, Inc. (PRME)
NASDAQ: PRME · Real-Time Price · USD
4.360
+0.230 (5.57%)
Feb 26, 2026, 1:18 PM EST - Market open
Prime Medicine Employees
Prime Medicine had 214 employees as of December 31, 2024. The number of employees decreased by 20 or -8.55% compared to the previous year.
Employees
214
Change (1Y)
-20
Growth (1Y)
-8.55%
Revenue / Employee
$27,930
Profits / Employee
-$922,145
Market Cap
771.89M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 214 | -20 | -8.55% |
| Dec 31, 2023 | 234 | 59 | 33.71% |
| Dec 31, 2022 | 175 | 74 | 73.27% |
| Sep 30, 2022 | 150 | 86 | 134.38% |
| Jun 30, 2022 | 137 | 73 | 114.06% |
| Mar 31, 2022 | 101 | - | - |
| Sep 30, 2021 | 64 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 837 |
| Replimune Group | 479 |
| ProKidney | 204 |
| Kura Oncology | 192 |
| Vor Biopharma | 154 |
| Alpha Tau Medical | 125 |
| Annexon | 99 |
| enGene Holdings | 82 |
PRME News
- 1 day ago - Prime Medicine to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 6 weeks ago - Prime Medicine, Inc. (PRME) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha
- 7 weeks ago - Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Prime: Maintaining 'Buy' On Solidified Catalysts For Wilson's Disease And Beyond - Seeking Alpha
- 2 months ago - Prime Medicine Announces The New England Journal of Medicine Publication of PM359 Clinical Data for the Treatment of Chronic Granulomatous Disease - GlobeNewsWire
- 3 months ago - Prime Medicine to Present at 8th Annual Evercore Healthcare Conference - GlobeNewsWire
- 3 months ago - Prime Medicine, Inc. (PRME) Discusses Liver Disease Franchise Strategy With Focus on Wilson Disease Transcript - Seeking Alpha
- 3 months ago - Prime Medicine to Present at Jefferies Global Healthcare Conference - GlobeNewsWire